๐๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐๐๐๐ผ๐ฐ๐ถ๐ฎ๐๐ฒ
โ ๐๐๐ก๐๐๐๐ก ๐๐๐๐๐ก๐ฆ | ๐ท๐๐ก๐ ๐ผ๐๐ก๐๐๐๐๐ก๐ฆ โ
๐ฃ: Wee-See-Ahn
๐๐ผ๐ฟ๐ป ๐ฎ๐ป๐ฑ ๐ฟ๐ฎ๐ถ๐๐ฒ๐ฑ ๐ถ๐ป ๐ฆ๐ถ๐ป๐ด๐ฎ๐ฝ๐ผ๐ฟ๐ฒ ๐ธ๐ฌ
๐๐
๐ฝ๐ฒ๐ฟ๐๐ถ๐๐ฒ:
๐ข Contract Research Organization
๐ ICH GCP E6 (R2)
๐ฅ Site Feasibility
๐ Regulatory Start-up๐ธ๐ฌ
๐ฌ Clinical Monitoring
๐ Pharmacovigilance
๐ Real World Data
๐ Pharmaceutical Translation
๐ง๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ฒ๐๐๐ถ๐ฐ ๐๐ฟ๐ฒ๐ฎ๐:
๐ฆ Oncology
โค๏ธ Cardiology
๐ฉธ Haematology
๐ฆ Infectious Diseases
๐ฃ๐ฎ๐ฟ๐ฎ๐ฑ๐ถ๐ด๐บ๐:
โญ๏ธ Decentralized Trials
โ ๏ธ Risk-based Monitoring
๐โโ๏ธ Patient-centricity
๐ฉ๐ป๐ฉ๐ผDiversity in Clinical Research๐ฉ๐ฝ๐ฉ๐พ
๐๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐ง๐ฟ๐ถ๐ฎ๐น๐ ๐๐
๐ฝ:
Phase 1๏ธโฃ
Phase 2๏ธโฃ
Phase 3๏ธโฃ
๐ฟ ๐ฆ๐ผ๐ณ๐๐๐ฎ๐ฟ๐ฒ ๐๐ผ๐บ๐ฝ๐ฒ๐๐ฒ๐ป๐ฐ๐ถ๐ฒ๐:
Clinical Trials Management System
Electronic Data Capture
Computer-assisted Translation
๐๐ฎ๐ป๐ด๐๐ฎ๐ด๐ฒ๐:
๐บ๐ธ English (EN-US/UK) ๐ฌ๐ง )
๐ฏ๐ต Japanese ๆฅๆฌ่ช (JA)
======================================
ใฆใฃใผใทใขใณใ็ณใใพใใฆใใทใณใฌใใผใซ็ใพใ่ฒใกใ่จๅบ้็บใขใใฟใผใ็ ไฟฎใใฆใใใพใ
๐งฌ ่จๅบ็ ็ฉถ | ๆฒป้จ | ่ฃฝ่ฌ | ใใคใชใใใฏ | CRO | CRA | ่ฌไบ็ณ่ซ | PV | ่กๆถฒๅญฆ | ไผๆ็
| ็้ ๅ | ๅพช็ฐๅจ | ๅผๅธๅจ | ๆ นๆ ใซๅบใฅใๅป็ | ๅป่ฌ็ฟป่จณ๐งฌ
๐ฎ ๅบงๅณใฎ้ใ
ใๆ่
ใฏ็ต้จใซๅญฆใณใ่ณข่
ใฏๆญดๅฒใซๅญฆใถใใ่ก้ๅฎฐ็ธใในใใซใฏ
โ๏ธ ๐ฅ๐ฒ๐ฎ๐ฐ๐ต ๐ผ๐๐ ๐๐ผ ๐บ๐ฒ ๐๐ถ๐ฎ ๐๐ถ๐ป๐ธ๐ฒ๐ฑ๐๐ป: http://linkedin.com/in/weesianglim
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
September 08, 2023 | 169 | +2 | +1.2% |
October 27, 2022 | 167 | +2 | +1.3% |
August 24, 2022 | 165 | +1 | +0.7% |
June 11, 2022 | 164 | -6 | -3.6% |
May 04, 2022 | 170 | +2 | +1.2% |
March 27, 2022 | 168 | +1 | +0.6% |
January 28, 2022 | 167 | +3 | +1.9% |
December 22, 2021 | 164 | +6 | +3.8% |
November 13, 2021 | 158 | -1 | -0.7% |
October 06, 2021 | 159 | +6 | +4.0% |